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Abstract
Background: Despite the substantial progress in the quality of critical care, the incidence and mortality of acute
kidney injury (AKI) continues to rise during hospital admissions. We conducted a national, multicenter, prospective,
epidemiological survey to evaluate the importance of AKI in intensive care units (ICUs) in Hungary. The objectives
of this study were to determine the incidence of AKI in ICU patients; to characterize the differences in aetiology,
illness severity and clinical practice; and to determine the influencing factors of the development of AKI and the
patients’ outcomes.
Methods: We analysed the demographic, morbidity, treatment modality and outcome data of patients (n = 459)
admitted to ICUs between October 1
st, 2009 and November 30
th, 2009 using a prospectively filled in electronic
survey form in 7 representative ICUs.
Results: The major reason for ICU admission was surgical in 64.3% of patients and medical in the remaining 35.7%.
One-hundred-twelve patients (24.4%) had AKI. By AKIN criteria 11.5% had Stage 1, 5.4% had Stage 2 and 7.4% had
Stage 3. In 44.0% of patients, AKI was associated with septic shock. Vasopressor treatment, SAPS II score, serum
creatinine on ICU admission and sepsis were the independent risk factors for development of any stage of AKI.
Among the Stage 3 patients (34) 50% received renal replacement therapy. The overall utilization of intermittent
renal replacement therapy was high (64.8%). The overall in-hospital mortality rate of AKI was 49% (55/112). The ICU
mortality rate was 39.3% (44/112). The independent risk factors for ICU mortality were age, mechanical ventilation,
SOFA score and AKI Stage 3.
Conclusions: For the first time we have established the incidence of AKI using the AKIN criteria in Hungarian ICUs.
Results of the present study confirm that AKI has a high incidence and is associated with high ICU and in-hospital
mortality.
Background
Despite improvements in the quality of critical care, the
incidence and mortality of acute kidney injury (AKI) con-
tinues to rise during hospital admission [1-3]. AKI has
been the focus of numerous publications and research
projects in the past 5 years. The incidence of AKI (during
hospital admission) ranges from 3 to 25% depending on
criteria applied. The variety of definitions used in clinical
studies may be partially responsible for the large varia-
tions in the reported incidence and the associated
mortality (19-83%) of AKI [4-7]. Today the two widely
accepted classification systems are the RIFLE criteria
[8,9] and the staging system for AKI as established by
Acute Dialysis Quality Initiative (ADQI) and the Acute
Kidney Injury Network (AKIN), respectively [10]. Under-
standing the changing spectrum of AKI is necessary to
facilitate quality improvement efforts and to design
successful epidemiological trials.
We have no controlled data about the epidemiology of
AKI in critically ill patients in Hungary. The aims of our
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its impact, in the context of other risk factors, on out-
comes (mortality, hospital- and ICU stay) and to com-
pare the findings to the international experience.
Methods
Study participants
This study is a national, multicenter, prospective, epide-
miological survey of AKI in 7 ICUs in Hungary. After ethi-
cal approval from each participating centre, we analysed
demographic, morbidity and outcome data of 459 adult
patients admitted to ICUs between October 1
st, 2009 and
November 30
th, 2009. The participating centres represent
the spectrum of Hungarian ICUs (each of them were
multidisciplinary non-cardiac ICU, representing the occur-
rence ratio of ICU patients in Hungary): two university
centres (University of Debrecen, University of Szeged),
three regional hospitals (Petz Aladar County Hospital
Gyor, Javorszky Odon Hospital Vac, Hetenyi Geza County
Hospital Szolnok,) and two city hospital (Dr. Kenessey
Albert Hospital Balassagyarmat, Szent Lukacs Hospital
Dombovar). During the two months of the study, every
newly admitted patient was registered in the survey and
was followed up until hospital discharge or death in
hospital.
Serum creatinine was determined at least once a day and
urine output was recorded hourly, for all patients. AKI was
defined and classified by the AKIN criteria [10], which has
only three stages. Stage 1 is defined as an abrupt (within
48 hours) reduction in kidney function currently defined
as an absolute increase in serum creatinine of more than
or equal to 0.3 mg/dl (≥ 26.4 μmol/l), a percentage
increase in serum creatinine of more than or equal to 50%
(1.5-fold from baseline), or a reduction in urine output
(documented oliguria of less than 0.5 ml/kg per hour
for more than six hours). Stage 2 is defined as doubling
of serum creatinine or a urinary output lower than 0.5 ml/
kg/h for 12 h. Stage 3 is defined as tripling of serum creati-
nine or a serum creatinine higher than 4 mg/dl if there is
an acute rise in serum creatinine of at least 0.5 mg/dl, or a
urinary output lower than 0.3 ml/kg/h for 24 h, or anuria
for 12 h. Stage 3 also includes patients who need renal
replacement therapy, irrespectively of the stage they are in,
at the time of renal replacement therapy.
Patients were categorized by serum creatinine and/or
urine output into the AKIN stages and the highest AKIN
stage during ICU staying was evaluated. Serum creatinine
on ICU admission was used as a reference value, staging
was based on the appropriate increase within the 48 hour
observation. Declines in serum creatinine were not coded
as AKI. Chronic kidney disease patients on dialysis (n = 3)
and theoretically the renal transplant patients (n = 0) were
excluded from the analysis. 12 patients had creatinine level
> 300 μmol/L on admission (severe AKI or unrecognized
chronic renal failure). These patients were involved into
the analysis.
Data collection
The Simplified Acute Physiology Score version II (SAPS
II) [11] and the Sepsis-related Organ Failure Assessment
Score (SOFA) [12] were used to evaluate severity of illness,
and were calculated based on the worst variables recorded
during the first 24 hours of ICU admission. The non-renal
SOFA score was calculated from the total SOFA score
minus the points for kidney insufficiency.
Multiple data were collected on each study participant,
including: demographics, co-morbidities, hospital and ICU
admission and discharge data, presumed aetiologies of
AKI, surgical procedures, nonsurgical procedures, and
renal replacement treatment modalities.
The aetiologies of AKI were identified from a group of
seven possible choices (septic shock, hypovolemia, cardio-
genic shock (these definitions were based on international
guidelines), surgical procedure, obstructive nephropathies,
drug-induced and others). Premorbid conditions were
chosen from the following possibilities (medical or surgical
admission; as well as cardiovascular, respiratory, gastroin-
testinal, neurological, and trauma diseases; malignancy,
and others). More than one condition could be selected in
each case.
The data were collected using an Excel-based data col-
lection file. This was available to each participating centre
with instructions. All centres were asked to complete the
data entry and e-mail the data to the organisation centre.
Upon arrival, all data were screened in detail by a dedi-
cated intensive care specialist for any missing information,
insufficient detail, or any other queries. Any queries gener-
ated an immediate e-mail inquiry with planned resolution
within 48 h.
Statistical analysis
All values were presented as mean values ± SD or as
median with interquartile range (IQR) as appropriate.
The mean values of the different groups were compared
using two-sided t-test, the median values by the Kolmo-
gorov-Smirnov test and the occurrence rates by the chi-
square test. A forward stepwise logistic regression analy-
sis (conditional) was perform to determine the indepen-
dent risk factors for AKI and mortality The included
variables were: age, gender, vasopressor requirement,
AKI stages, SOFA, SAPS II, creatinine level at ICU
admission and the maximum level during ICU staying,
surgical/medical admission, the different diseases, sepsis,
mechanical ventilation, as appropriate. All variables were
deemed to be significant if p <0 . 0 5 .A l la n a l y s i sw a sp e r -
formed by the SPSS statistical software package 15.0.
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Characteristics of the occurrence of AKI
Altogether 459 patients (aged 59.6 ± 16.2 years, male/
female ratio 258/201) were entered into the study. Base-
line characteristics of the patients are summarized in
T a b l e1 .B e c a u s et h e r ew e r en os i g n i f i c a n td i f f e r e n c e s
among the examined variables in respect of the gender,
in the following analyses the data were drawn together.
AKI patients (n = 112) tended to be older (64.9 vs. 57.6
years, p < 0.001) and usually had more severe underlying
diseases (SAPS II. 47.5 vs. 22, p < 0.001, SOFA 6 vs. 2,
p < 0.001). The proportion of patients who needed
mechanical ventilation during their ICU stay differed sig-
nificantly in patients without or with AKI (33.4% and
75.0%, p < 0.001) A similar difference was also observed
in the vasopressor needs (12.1% vs. 51.8% in patients
without and with AKI, respectively, p = 0.0018).
T h ei n c i d e n c eo fA K Iw a s2 4 . 4 % .B yA K I Nc r i t e r i a5 3
patients (11.5%) were in Stage 1, 25 patients (5.5%) in
Stage 2 and 34 patients (7.4%) in Stage 3. Seventeen
patients (15.2% of the AKI cases) had received renal repla-
cement therapy.
The major reason for ICU admission was surgical in
64.3% (gastrointestinal tract surgery was the most com-
mon), followed by neurological, cardiovascular, pulmonary
diseases and trauma cases (Table 2).
In 44.0% of patients, AKI was associated with septic
shock (Figure 1). Sixteen percent of AKI was associated
with major surgery, 20% was related to cardiogenic
shock, 39% was related to hypovolemia, and 2% of AKI
was potentially drug-related.
A logistic regression analysis was performed to analyse
the predisposing factors for the incidence of AKI. Among
the analysed parameters vasopressor treatment, SAPS II
score, serum creatinine on ICU admission and sepsis were
the independent risk factors for development of any stage
of AKI (Table 3). The same distribution was found when
the independent predisposing factors for AKI Stage 3 were
evaluated.
Renal replacement therapy
Among AKI Stage 3 patients 50% (17/34) received renal
replacement therapy. The overall utilization of intermit-
tent renal replacement therapy (IRRT) was high, with
64.8% (among all patients with RRT). All patients were
treated with a veno-venous technique. The most com-
mon mode in the IRRT group was IHD (88%) and in
the CRRT group CVVHDF (94%). The median filtration
dose was a regimen of 20 mL/kg/h.
Mortality and lengths of stay
The overall in-hospital mortality rate of AKI was 49.1%
(55/112). The ICU mortality rate was 39.3% (44/112)
(Table 4). Any degree of AKI was associated with a sig-
nificantly increased all-cause ICU (39.3% vs. 9.5%, p <
0.001) and overall mortality (49.1% vs. 16.1% p < 0.001)
compared with not having AKI. For patients admitted
with AKI to the ICU, the median length of stay at the
ICU increased by 120% (2 vs. 4.5 day, p < 0.0001) and the
median length of hospitalization by 35% (10 vs. 13.5 day,
p = 0.005), compared to patient without AKI. According
to the logistic regression analysis (Table 5) age, mechani-
cal ventilation, SOFA score and AKI Stage 3 were found
as independent risk factors for ICU mortality. In respect
of the hospital mortality only the higher age, the need of
vasopressor treatment and the neurological diseases were
the independent risk factors for the mortality.
Discussion
T h ei n c r e a s e di n c i d e n c eo fA K Ii sm o s tl i k e l yd u et oa
trend of admitting older, more severely and more chroni-
cally ill patients to hospitals [7,13-16]. Different studies
describe a wide range of AKI (5.2%-67.2%) [14,17-19],
w h i c hv a r i e sa c r o s si n t e n s i v ec a r eu n i t sa n da d m i s s i o n
diagnoses [20-25]. There are two studies which assessed
the prevalence according to the AKIN criteria [14,19]
and have found it between 22%-35.5%, with different
degrees of severity: AKI 1: 17.5%-19.1%, AKI 2: 2.4%-
3.8% and AKI 3: 2%-12.5%. Joannidis M and co-workers
Table 1 Characteristics of patients during ICU staying
Parameters All patient AKI non-AKI p-AKI vs.non-AKI
Patient number n (%) 459 112 (24.4) 347 (75.6)
Age (year), mean ± SD 59.6 ± 16.2 64.9 ± 14.4 57.6 ± 16.3 < 0001
SAPS II. score, median (IQR) 28 (16, 46) 47.5 (33, 59) 22 (14, 38) < 0.001
SOFA score, median (IQR) 4 (1, 7) 6 (4, 9.25) 2 (1, 5.5) < 0.001
SOFAnon renal, median (IQR) 6 (3, 9)
Se-creatinine at ICU admission (μmol/L), median (IQR) 76 (59, 103) 117.5 (81, 205) 70 (57, 87) < 0.001
Se-creatinine peak-concentration (μmol/L), median (IQR) 80 (61, 112) 165.5 (112, 274) 71 (58, 89) < 0.001
Mechanical ventilation, n (%) 200 (43.6) 84 (75) 116 (33.4) < 0.001
Ventilator days, median (IQR) 3 (1, 7) 3.5 (2, 11) 2 (1, 7) 0.177
Vasopressor treatment, n (%) 100 (21.8) 58 (51.8) 42 (12.1) 0.002
Vasopressor hours, median (IQR) 49 (24, 96) 48 (24, 99) 63 (18, 92) 0.619
Medve et al. BMC Nephrology 2011, 12:43
http://www.biomedcentral.com/1471-2369/12/43
Page 3 of 7analysed by AKIN criteria the SAPS 3 database, found the
incidence 28.5%, that is very similar to our data (24.4%)
[ 2 6 ] .W h i l e ,t h e yd i d n ’t found the difference between
AKI 1 and 2, in our study AKI 1 (11.5%) was double to
AKI 2 (5.5%). The difference may arise from the fact, that
they assessing urine-output only at 24-hours intervals
and could not distinguish between the AKIN stage 1 and
2. We found that the incidence of 7.4% in AKI 3 is better
comparable to the data of Osterman [14] and Thakar
[19], than the incidence of 13.8% of a cohort analysis
[26].
We could demonstrate that the incidence rate of AKI is
highest in elderly patients, who make up an ever-growing
segment of the population. In the aging population, there
is heightened susceptibility to drug toxicity, partially
owing to altered drug pharmacokinetics and pharmaco-
dynamics. Furthermore, elderly people consume twice as
many medications overall, including nephrotoxic agents,
than younger patients [16,27]. In our study, AKI patients
were significantly older with significantly higher severity
scores. We could prove that the higher SAPS II. score is
an independent risk factor for AKI.
Renal dysfunction has a close association with the
duration and weaning from mechanical ventilation [28].
Mechanical ventilation and vasopressor requirements
were significantly higher in patients with AKI than in
patients without AKI. Although, we could not distinguish
that the mechanical ventilation or the vasopressor treat-
ment was a cause or a consequent of AKI, we found a
close relationship between them. Vasopressor treatment
was a risk factor for the development of any stages of
AKI, while mechanical ventilation was an independent
risk factor for ICU mortality.
AKI has long been recognized as a devastating compli-
cation after surgery [3,29] and postoperative AKI remains
a leading cause of morbidity, mortality and prolonged
hospital stay [18,21,29-32]. Despite the widespread recog-
nition of increased risk for AKI following a variety of sur-
gical procedures, the pathogenesis of this syndrome is
poorly understood in all of these settings. We can esti-
mate that approximately thirty percent of AKI was asso-
ciated with abdominal surgery [29,30]. Inadequate renal
perfusion pressure caused by complicated abdominal sur-
g e r yi so n eo ft h ek e yf a c t o r si nt h ed e v e l o p m e n to f
intraabdominal pressure (IAP)-induced kidney injury.
Changes in IAP may have a great impact on renal func-
tion and urine output. Currently available data on AKI
and its consequences suggest that AKI has the potential
to substantially alter the outcome of patients with cancer
[33]. The high incidence of abdominal surgery (37%) and
malignancy (13%) in our patients with AKI indicates a
major role of these conditions in the development of
AKI.
The multicentre European Sepsis Occurrence in
Acutely Ill Patients (SOAP) study [34] found that 51% of
septic patients developed AKI. More recently, in a 1-day
point prevalence survey for severe sepsis/septic shock
from 454 ICUs in Germany, Oppert and co-workers [35]
reported concomitant AKI in 41.4% of septic patients.
Table 2 Type and reason of ICU admissions
Reason for ICU admission All patient
(n = 459)
non-AKI
(n = 347)
Acute kidney Injury p-AKI vs. non-AKI
Stage 1
(n = 53)
Stage 2
(n = 25)
Stage 3
(n = 34)
AKI all
(n = 112)
Surgical 295 (64%) 241 (69%) 27 (24%) 17 (15%) 10 (9%) 54 (48%) < 0.001
Medical 164 (36%) 106 (31%) 26 (23%) 8 (7%) 24 (22%) 58 (52%)
Cardiovascular 84 (18%) 60 (17%) 8 (7%) 6 (5%) 10 (9%) 24 (21%) 0.417
Respiratory 67 (15%) 57 (16%) 6 (5%) 0 4 (4%) 10 (9%) 0.086
Malignancy 126 (27%) 111 (32%) 9 (8%) 5 (4%) 1 (1%) 15 (13%) 0.002
Gastrointestinal 135 (29%) 92 (27%) 20 (18%) 12 (11%) 9 (8%) 41 (37%) 0.136
Neurological 85 (19%) 72 (21%) 11 (10%) 1 (1%) 1 (1%) 13 (12%) 0.067
Trauma surgery 50 (11%) 42 (12%) 6 (5%) 1 (1%) 1 (1%) 8 (7%) 0.184
Others 63 (14%) 42 (12%) 4 (4%) 7 (6%) 9 (8%) 20 (18%) 0.182
Case numbers and percentage ratios, according to the appropriate groups.
Figure 1 Contributing Factors to Acute Kidney Injury.
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critically ill patients with AKI found sepsis to be a contri-
buting factor in 46% to 48% of episodes of AKI [3,35]. In
our study, sepsis was also the leading etiologic factor (in
44% of patients) of AKI, and was a highly significant
independent risk factor for AKI.
Cardiogenic shock associated renal hypoperfusion is
strongly associated with AKI. The incidence of acute
cardio-renal syndrome in patients with AKI is estimated
to be between 19% and 45% [36]. In a large cohort
study of patient after cardiac arrest [37], it was found
that AKI occurs in nearly 50% of patients when the
AKIN criteria were applied. This indicates that the
severity of hypoxia/ischemia may also have an effect on
the development of AKI. Marenzi et al [38] found that
in the setting of ST-elevation acute myocardial infarc-
tion, complicated by cardiogenic shock, AKI occurred in
55% of patients. In our study 20% of AKI was related to
cardiogenic shock.
Hypovolemia-associated prerenal failure, an important
contributing factor to AKI was noted in 36% of our AKI
patients. Since our study protocol did not require an
invasive hemodynamic monitoring, we could not assess
exactly the volume-status of patients on ICU-admission.
We evaluated it as a major limitation of our study
because the diagnosis of hypovolemia was based mainly
on basic hemodynamic data and clinical impressions.
However, AKIN criteria do not determine specific diag-
nostic criteria to classify prerenal conditions. Because of
the lack of standardized definitions and the difficulty in
assessing reversibility of AKI, the concept of prerenal
failure has been recently challenged [39].
It is known, that primary renal failure, secondary to a
variety of pathologic conditions affecting the kidney, is
usually treated in non-intensive care units and has rela-
tively good prognosis and low mortality (5-10%) [40,41].
In contrast, the onset of AKI, as a part of multiple
organ failure has 50-70% mortality [5,18]. Osterman et
al [14] report that applying AKIN criteria, the mortality
of AKI is the following: AKI 1: 20.1%, AKI 2: 25.9%,
AKI 3: 49.6%. In our study the mortality was much
higher: AKI all 41.3%, AKI 1 35.8%, AKI 2 44.0%, AKI 3
73.5%). The higher mortality of AKI in Hungarian ICUs
can be explained also by factors, such as higher inci-
dence of malignancy and non-uniform treatment princi-
ples. In the cohort analysis of Joannidis et al [26] 6.1%
of AKI was related to non-metastatic cancer patients,
while in our study it was 13%. The other reason may be
that in Hungary there are not uniform protocols for
treatment of AKI (different: the timing of RRT, the
treatment modalities and doses of RRT, continuous vs.
intermittent diuretic therapy). In our study the age, the
sepsis related variables (vasopressor treatment, mechani-
cal ventilation, SOFA score) and the AKI Stage 3 were
Table 3 Stepwise logistic regression analysis of the variables for the incidence of AKI focused on AKI all and AKI Stage
3 versus non-AKI patients
Variables Coefficient SE Wald test P value Odds Ratio 95% CI
lower upper
AKI all Vasopressor treatment 2.727 0.680 16.078 < 0.001 15.290 13.930 16.650
SAPS II score 0.040 0.017 5.554 0.018 1.041 1.007 1.075
Se creatinine at ICU admission 0.008 0.002 18.517 < 0.001 1.008 1.004 1.012
Sepsis 1.980 0.544 13.225 < 0.001 7.242 6.234 8.250
AKI Stage 3 Vasopressor treatment 2.186 0.593 13.579 < 0.001 8.897 7.711 10.083
SAPS II score 0.018 0.008 5.694 0.017 1.018 1.002 1.034
Se creatinine at ICU admission 0.007 0.002 14.375 < 0.001 1.007 1.003 1.011
Sepsis 1.574 0.500 9.907 0.002 4.827 3.827 5.827
SE, standard error; 95% CI, 95% confidence interval.
Table 4 Mortality and length of stay
Parameters All patients
(n = 459)
non-AKI
(n = 347)
Acute Kidney Injury p-AKI all vs. non-AKI
Stage 1
(n = 53)
Stage 2
(n = 25)
Stage 3
(n = 34)
AKI all
(n = 112)
ICU-s stay (days), median (IQR) 2 (2,5) 2 (2,4) 4 (2,8) 5 (3,14) 6 (2,18) 4.5 (2,13) < 0.001
In-hospital stay (days), median (IQR) 11 (7,16) 10 (7,14) 14 (5,18) 12 (7,24) 14 (4,29) 13.5 (5,20) 0.015
Overall mortality, n (%) 111 (24.2) 56 (16.1) 19 (35.9) 11 (44) 25 (73.5) 55 (49.1) < 0.001
ICU-s mortality, n (%) 77 (16.8) 33 (9.5) 14 (26.4) 10 (40) 20 (58.8) 44 (39.3) < 0.001
In-hospital mortality after ICU, n (%) 34 (7.4) 23 (6.6) 5 (9.4) 1 (4.0) 5 (14.7) 11 (9.8) 0.301
Medve et al. BMC Nephrology 2011, 12:43
http://www.biomedcentral.com/1471-2369/12/43
Page 5 of 7the highly significant risk factors for the ICU and the
hospital mortality.
The limitations of our study: Hypovolemia was not
e x c l u s i o nc r i t e r i ai nc l a s s i fication by AKIN. We applied
early goal directed volume resuscitation, while followed
the urine output hourly. If during the first six hours period
the urine output raised above 0.5 ml/kg/h we didn’t classi-
fied the patient for AKI 1 stage. Secondly, the Hungarian
ICU-s hasn’t uniform protocol for treatment of AKI, so we
couldn’t compare the different ICU-s. Finally, we didn’t
distinguish early and late AKI.
Conclusion
We have conducted a national, multicenter, prospective,
epidemiological study on AKI, occurring at representative
Hungarian ICUs. For the first time, we have established
the incidence of AKI using the AKIN criteria at Hungar-
i a nI C U s .T h er e s u l t so ft h ep r e s e n ts t u d yc o n f i r mt h a t
AKI has a high incidence and is associated with higher
ICU and in-hospital mortality. AKI doubles length of stay
at the ICU and the duration of hospital staying. The inde-
pendent risk factors for the development of any stage of
AKI were SAPS II score, serum creatinine on ICU admis-
sion, sepsis and vasopressort r e a t m e n t .A g e ,s e p s i s
related variables (vasopressor treatment, mechanical ven-
tilation, SOFA score) and AKI Stage 3 were the highly
significant risk factors for the ICU and the hospital
mortality.
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